Always open to unsubstantiated comments but....It seems that ICDX is gaining more momentum http://www.reuters.com/article/2013/11/12/tin-indonesia-idUSL5N0IT05820131112
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status